*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Analytical Method Development and Validation of Macitentan by RP-HPLC Method

Author: CHABALA OBIREDDY, CHANDAN R S, BARATH M, ANAND KUMAR TENGLI
Abstract: Macitentan is an endothelin receptor antagonist authorized for Pulmonary arterial hypertension therapy. Endothelin is a highly active agent constricting blood vessels that is naturally produced by endothelial cells. By inhibiting the binding of ET-1 to ET receptors, Macitentan inhibits the ET1-dependent Which increase the intracellular calcium. Therefore, an accurate, fast, simple and cost-effective RP-HPLC technique for detecting Macitentan was developed. The RP-HPLC method is developed by using ACN and Acetate buffer 80:20 v/v as MP, the Flow rate is maintained at 1.5 mL/minute. Detection of Macitentan was performed by using UV detector at 263nm. By this proposed method RT of Macitentan was identified at 3.1 min. The method was validated concerning system suitability, linearity, accuracy, precision, robustness and ruggedness according to ICH guidelines
Keyword: UV detector, RP-HPLC method, Macitentan, ICH guidelines.
DOI: https://doi.org/10.31838/ijpr/2021.13.02.061
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free